A novel mutation leading to the lethal form of carnitine palmitoyltransferase type-2 deficiency


Dorum S., Varal I. G., Gorukmez O., Dogan P., Ekici A.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.32, sa.7, ss.781-783, 2019 (SCI-Expanded) identifier identifier identifier

Özet

Background: The clinical phenotypes of carnitine palmitoyltransferase type-2 deficiency (CPT2D) are classified into lethal neonatal, severe infantile and muscle forms. The rarest form is the lethal neonatal form.